litlas
ログインアカウント作成

Giuseppe Saglio

1976–2025 年に発表

165
論文数
43,748
被引用数
100
h 指数
163
i10 指数

被引用数

Giuseppe Saglio の年別被引用数1977 年: 被引用 1 件1979 年: 被引用 21 件1980 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 5 件1985 年: 被引用 3 件1986 年: 被引用 1 件1987 年: 被引用 3 件1988 年: 被引用 5 件1989 年: 被引用 7 件1990 年: 被引用 9 件1991 年: 被引用 11 件1992 年: 被引用 10 件1993 年: 被引用 17 件1994 年: 被引用 16 件1995 年: 被引用 17 件1996 年: 被引用 25 件1997 年: 被引用 29 件1998 年: 被引用 51 件1999 年: 被引用 86 件2000 年: 被引用 70 件2001 年: 被引用 75 件2002 年: 被引用 110 件2003 年: 被引用 165 件2004 年: 被引用 141 件2005 年: 被引用 175 件2006 年: 被引用 192 件2007 年: 被引用 304 件2008 年: 被引用 291 件2009 年: 被引用 372 件2010 年: 被引用 378 件2011 年: 被引用 376 件2012 年: 被引用 346 件2013 年: 被引用 340 件2014 年: 被引用 319 件2015 年: 被引用 331 件2016 年: 被引用 333 件2017 年: 被引用 260 件2018 年: 被引用 239 件2019 年: 被引用 877 件2020 年: 被引用 979 件2021 年: 被引用 866 件2022 年: 被引用 625 件2023 年: 被引用 391 件2024 年: 被引用 748 件2025 年: 被引用 237 件2026 年: 被引用 2 件1978 年は被引用が無いため表示していません1981 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,370 件、この内訳の 23.9%イタリア: 引用元論文 937 件、この内訳の 9.5%ドイツ: 引用元論文 805 件、この内訳の 8.1%イギリス: 引用元論文 719 件、この内訳の 7.3%フランス: 引用元論文 586 件、この内訳の 5.9%中国: 引用元論文 517 件、この内訳の 5.2%オランダ: 引用元論文 313 件、この内訳の 3.2%スペイン: 引用元論文 299 件、この内訳の 3%オーストラリア: 引用元論文 272 件、この内訳の 2.7%スイス: 引用元論文 268 件、この内訳の 2.7%カナダ: 引用元論文 259 件、この内訳の 2.6%日本: 引用元論文 239 件、この内訳の 2.4%
0%23.9%その他 23.5%

機関

分野

  • Medicine72.7%
  • Biochemistry, Genetics and Molecular Biology20%
  • Immunology and Microbiology3.2%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Computer Science0.8%
  • Materials Science0.4%
  • その他2%

トピック

  • Chronic Myeloid Leukemia Treatments12.5%
  • Acute Myeloid Leukemia Research9.4%
  • Chronic Lymphocytic Leukemia Research7.1%
  • Eosinophilic Disorders and Syndromes5.2%
  • Acute Lymphoblastic Leukemia research4.6%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.9%
  • その他58.3%

共著者

全論文

検索で開く
  1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

    著者: Andreas Hochhaus, Michele Baccarani, Richard T. Silver, CA Schiffer, Jane F. Apperley, Francisco Cervantes, R E Clark, J. E. Cortes, Michael W. Deininger, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, J. Janssen, Hagop M. Kantarjian, D. W. Kim, Richard A. Larson, J. H. Lipton, F.-X. Mahon, Jiří Mayer, Franck E. Nicolini, D Niederwieser, Fabrizio Pane, Jerald P. Radich, Delphine Réa, Johan Richter, G Rosti, Philipe Rousselot, Giuseppe Saglio, Susanne Saußele, Simona Soverini, J. L. Steegmann, Anna Turkina, Andrey Zaritskey, R. Hehlmann - Leukemia 2020 被引用: 1,510

  2. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial

    著者: Jörge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiřı́ Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luís Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus - Journal of Clinical Oncology 2016 被引用: 946

  3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  4. Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

    著者: Hagop M. Kantarjian, Timothy P. Hughes, Richard A. Larson, Dong‐Wook Kim, Surapol Issaragrisil, Philipp le Coutre, Gabriel Étienne, Carla Boquimpani, Ricardo Pasqüini, Richard E. Clark, Viviane Dubruille, Ian W. Flinn, Sławomira Kyrcz‐Krzemień, Ewa Mędraś, Maria Aparecida Zanichelli, Israel Bendit, Silvia Cacciatore, Ksenia Titorenko, Paola Aimone, Giuseppe Saglio, Andreas Hochhaus - Leukemia 2021 被引用: 351

  5. Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype

    著者: Brunangelo Falini, Cristina Mecucci, Enrico Tiacci, Myriam Alcalay, Roberto Rosati, Laura Pasqualucci, Roberta La Starza, Daniela Diverio, Emanuela Colombo, Antonella Santucci, Barbara Bigerna, Roberta Pacini, Alessandra Pucciarini, Arcangelo Liso, Marco Vignetti, Paola Fazi, Natalia Meani, Valentina Pettirossi, Giuseppe Saglio, Franco Mandelli, Francesco Lo‐Coco, Pier Giuseppe Pelicci, Massimo F. Martelli - New England Journal of Medicine 2005 被引用: 1,885

  6. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

    著者: Stephen G. O’Brien, François Guilhot, Richard A. Larson, Insa Gathmann, Michele Baccarani, Francisco Cervantes, Jan J. Cornelissen, Thomas Fischer, Andreas Hochhaus, Timothy P. Hughes, Klaus Lechner, Johan Lanng Nielsen, Philippe Rousselot, Josy Reiffers, Giuseppe Saglio, John D. Shepherd, Bengt Simonsson, Aloïs Gratwohl, John M. Goldman, Hagop M. Kantarjian, Kerry Taylor, Gregor Verhoef, Ann E. Bolton, Renaud Capdeville, Brian Druker - New England Journal of Medicine 2003 被引用: 3,565

  7. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

    著者: Andreas Hochhaus, Giuseppe Saglio, Timothy P. Hughes, Richard A. Larson, D-W Kim, Surapol Issaragrisil, Philipp D. le Coutre, Gabriel Étienne, P.E. Dorlhiac‐Llacer, Richard E. Clark, Ian W. Flinn, Hirohisa Nakamae, Breanne Donohue, Weiping Deng, Darshan Dalal, Hans D. Menssen, Hagop M. Kantarjian - Leukemia 2016 被引用: 850

  8. Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

    著者: Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil, P. Le Coutre, Gabriel Étienne, Clarisse Lobo, Ricardo Pasqüini, Richard E. Clark, Andreas Hochhaus, Timothy P. Hughes, Neil J. Gallagher, Albert Hoenekopp, Mei Dong, Md Ariful Haque, Richard A. Larson, Hagop M. Kantarjian - New England Journal of Medicine 2010 被引用: 1,679

  9. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    著者: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 被引用: 1,989

  10. Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

    著者: Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E. Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotić, Loree Larratt, Fritz Offner, Gary J. Schiller, Ronan Swords, Larry Bacon, Monica Bocchia, Krimo Bouabdallah, Dimitri Breems, Agostino Cortelezzi, Shira Dinner, Michael Doubek, Bjørn Tore Gjertsen, Marco Gobbi, Andrzej Hellmann, Stéphane Leprêtre, Frédéric Maloisel, Farhad Ravandi, Philippe Rousselot, Mathias Rummel, Tanya Siddiqi, Tamar Tadmor, Xavier Troussard, Cecilia Arana Yi, Giuseppe Saglio, Gail J. Roboz, Kemal Balic, Nathan Standifer, Peng He, Shannon Marshall, Wyndham H. Wilson, Ira Pastan, Nai-Shun Yao, Francis J. Giles - Leukemia 2018 被引用: 247

  11. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    著者: J Gäbert, Emmanuel Beillard, Vincent H. J. van der Velden, W Bi, David Grimwade, Niels Pallisgaard, Gisela Barbany, Giovanni Cazzaniga, J M Cayuela, Hélène Cavé, Fabrizio Pane, Joeri L. Aerts, Daniela De Micheli, Xavier Thirion, Vincent Pradel, Marcos González, Susanne Viehmann, M Malec, Giuseppe Saglio, Jacques J. M. van Dongen - Leukemia 2003 被引用: 1,528

  12. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

    著者: Andreas Hochhaus, Tamás Masszi, Francis J. Giles, Jerald P. Radich, David M. Ross, M T Gómez Casares, Andrzej Hellmann, Jesper Stentoft, Eibhlin Conneally, Valentín García‐Gutiérrez, Norbert Gattermann, W Wiktor-Jędrzejczak, Philipp D. le Coutre, B. Martino, Susanne Saußele, Hans D. Menssen, Weiping Deng, Nancy Krunic, Véronique Bédoucha, Giuseppe Saglio - Leukemia 2017 被引用: 287

  13. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

    著者: Corrado Girmenia, Gian María Rossolini, Alfonso Piciocchi, Alice Bertaina, Giovanni Pisapia, Domenico Pastore, Simona Sica, Alessandro Severino, Laura Cudillo, Fabio Ciceri, Rosanna Scimè, Letizia Lombardini, Claudio Viscoli, Alessandro Rambaldi, the Gruppo Italiano Trapianto Midollo Osseo (GITMO), Marco Frigeni, Alessandro Rambaldi, Consuelo Corti, Fabio Ciceri, Gabriella Mometto, C. Annaloro, Erminia Casari, Luca Castagna, Giuseppe Rossi, Chiara Cattaneo, Domenico Russo, Valeria Cancelli, Emilio Paolo Alessandrino, Francesco Ripamonti, Fabio Pavan, Attilio Rovelli, Clara Pecoraro, Alessandro Busca, Francesca Carraro, Franca Fagioli, Susanna Gallo, Daniele Caravelli, Marco De Gobbi, Giuseppe Saglio, Claudia Castellino, Nicola Mordini, Gianluca Gaïdano, Luca Nassi, R Raimondi, Michele Vespignani, Anna Maria Scattolin, Irene Sara Panizzolo, Simone Cesaro, Anna Candoni, Francesca Patriarca, Andrea Bacigalupo, Anna Maria Raiola, Elio Castagnola, Edoardo Lanino, Marta Stanzani, Giuseppe Bandini, Erika Massaccesi, Arcangelo Prete, Simona Bassi, Daniele Vallisa, Cecilia Caramatti, Franco Aversa, Eliana Zuffa, Stefano Guidi, Alberto Bosi, Veronica Tintori, Anna Paola Iori, Saveria Capria, Laura Cudillo, William Arcese, Teresa Dentamaro, Paolo de Fabritiis, Barbara Anaclerico, Anna Chierichini, Monica Piedimonte, Antonella Ferrari, Francesco Marchesi, Andrea Mengarelli, Elisabetta Cerchiara, Maria Cristina Tirindelli, Javid Gaziev, Alessandro Severino, Ignazio Majolino, Patrizia Chiusolo, Simona Sica, Alice Bertaina, Barbarella Lucarelli, Maria Speranza Massei, Alessandra Carotti, Katia Perruccio, Maurizio Caniglia, Stella Santarone, Paolo Di Bartolomeo, Serena Mazzotta, Piero Galieni, Attilio Olivieri, Gennaro De Rosa, Antonio M. Risitano, Mario Delia, Giorgina Specchia ほか 12 名 - Bone Marrow Transplantation 2014 被引用: 188

  14. First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis

    著者: Claudia Vener, Rita Banzi, Federico Ambrogi, Annalisa Ferrero, Giuseppe Saglio, Gabriella Pravettoni, Milena Sant - Blood Advances 2020 被引用: 132

  15. Chronic myeloid leukemia stem cells

    著者: Mohammad Houshmand, Giorgia Simonetti, Paola Circosta, Valentina Gaidano, Alessandro Cignetti, Giovanni Martinelli, Giuseppe Saglio, Robert Peter Gale - Leukemia 2019 被引用: 175

  16. IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report

    著者: Giovanni Martinelli, Ilaria Iacobucci, Clelia Tiziana Storlazzi, Marco Vignetti, Francesca Paoloni, Daniela Cilloni, Simona Soverini, Antonella Vitale, Sabina Chiaretti, Giuseppe Cimino, Cristina Papayannidis, Stefania Paolini, Loredana Elia, Paola Fazi, Giovanna Meloni, Sergio Amadori, Giuseppe Saglio, Fabrizio Pane, Michele Baccarani, Robin Foà - Journal of Clinical Oncology 2009 被引用: 322

  17. Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

    著者: Jerald P. Radich, Andreas Hochhaus, Tamás Masszi, Andrzej Hellmann, Jesper Stentoft, María Teresa Gómez‐Casares, Valentín García‐Gutiérrez, Eibhlin Conneally, Philipp D. le Coutre, Norbert Gattermann, Bruno Martino, Susanne Saußele, Francis J. Giles, David M. Ross, Paola Aimone, Sai Li, Ksenia Titorenko, Giuseppe Saglio - Leukemia 2021 被引用: 86

  18. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

    著者: Michele Baccarani, Jörge E. Cortes, Fabrizio Pane, Dietger Niederwieser, Giuseppe Saglio, Jane F. Apperley, Francisco Cervantes, Michael W. Deininger, Aloïs Gratwohl, François Guilhot, Andreas Hochhaus, Mary M. Horowitz, Timothy P. Hughes, Hagop M. Kantarjian, Richard A. Larson, Jerald P. Radich, Bengt Simonsson, Richard T. Silver, John M. Goldman, Rüdiger Hehlmann - Journal of Clinical Oncology 2009 被引用: 1,298

  19. Molecular Pathways: BCR-ABL

    著者: Daniela Cilloni, Giuseppe Saglio - Clinical Cancer Research 2011 被引用: 267

  20. Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

    著者: Hagop M. Kantarjian, Francis J. Giles, Kapil N. Bhalla, Javier Pinilla‐Ibarz, Richard A. Larson, Norbert Gattermann, Oliver G. Ottmann, Andreas Hochhaus, Jerald P. Radich, Giuseppe Saglio, Timothy P. Hughes, Giovanni Martinelli, Dong-Wook Kim, Yaping Shou, Neil J. Gallagher, Rick E. Blakesley, Michele Baccarani, Jörge E. Cortes, Philipp D. le Coutre - Blood 2010 被引用: 379

  21. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    著者: Simona Soverini, Andreas Hochhaus, Franck E. Nicolini, Franz Gruber, Thoralf Lange, Giuseppe Saglio, Fabrizio Pane, Martin C. Müller, Thomas Ernst, Gianantonio Rosti, Kimmo Porkka, Michele Baccarani, Nicholas C.P. Cross, Giovanni Martinelli - Blood 2011 被引用: 579

  22. Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034

    著者: Neil P. Shah, Philippe Rousselot, Charles A. Schiffer, Delphine Réa, Jörge E. Cortes, Jorge Milone, Hesham Mohamed, Diane Healey, Hagop M. Kantarjian, Andreas Hochhaus, Giuseppe Saglio - American Journal of Hematology 2016 被引用: 181

  23. Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

    著者: Daniela Cilloni, Aline Renneville, Fabienne Hermitte, Robert K. Hills, Sarah B. Daly, Jelena Jovanović, Enrico Gottardi, Milena Fava, Susanne Schnittger, Tamara Weiss, Barbara Izzo, Josep Nomdedéu, Adrian van der Heijden, Bert A. van der Reijden, Joop H. Jansen, Vincent H. J. van der Velden, Hans Beier Ommen, Claude Preudhomme, Giuseppe Saglio, David Grimwade - Journal of Clinical Oncology 2009 被引用: 434

  24. Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

    著者: Nicholas C.P. Cross, Helen White, Dolors Colomer, Hans Ehrencrona, Letizia Foroni, Enrico Gottardi, Thoralf Lange, Thomas Lion, Kateřina Machová Poláková, Stéphanie Dulucq, Giovanni Martinelli, Elisabeth Oppliger Leibundgut, Niels Pallisgaard, Gisela Barbany, Tomasz Sacha, Rodica Tălmaci, Barbara Izzo, Giuseppe Saglio, Fabrizio Pane, Martin C. Müller, Andreas Hochhaus - Leukemia 2015 被引用: 342